Peritoneal Dialysis–Related Peritonitis: Atypical and Resistant Organisms

Catalan, 2005, 3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis, Kidney Int, 68, 1303, 10.1111/j.1523-1755.2005.00528.x van Bronswijk, 1989, Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro, Perit Dial Int, 9, 197, 10.1177/089686088900900310 Williams, 2002, Morphologic changes in the peritoneal membrane of patients with renal disease, J Am Soc Nephrol, 13, 470, 10.1681/ASN.V132470 Brown F., Gulyani A., McDonald S., Hurst K. Chapter 6: peritoneal dialysis. ANZDATA 2012 annual report. 35th ed. 2012. [cited 2015 November 21] Available from: http://www.anzdata.org.au/anzdata/AnzdataReport/35thReport/2012c06_peritoneal_v3.pdf. Boudville, 2012, Recent peritonitis associates with mortality among patients treated with peritoneal dialysis, J Am Soc Nephrol, 23, 1398, 10.1681/ASN.2011121135 Troidle, 2006, Treatment and outcome of CPD-associated peritonitis, Ann Clin Microbiol Antimicrob, 5, 6, 10.1186/1476-0711-5-6 Piraino, 2011, ISPD position statement on reducing the risks of peritoneal dialysis-related infections, Perit Dial Int, 31, 614, 10.3747/pdi.2011.00057 Fahim, 2010, Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases, Am J Kidney Dis, 55, 690, 10.1053/j.ajkd.2009.11.015 Rubin, 1983, Host defense mechanisms in continuous ambulatory peritoneal dialysis, Clin Nephrol, 20, 140 Lawn, 2011, Tuberculosis, Lancet, 378, 57, 10.1016/S0140-6736(10)62173-3 Talwani, 2000, Tuberculous peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: case report and review, Clin Infect Dis, 31, 70, 10.1086/313919 Sasaki, 1979, Ten years’ survey of dialysis-associated tuberculosis, Nephron, 24, 141, 10.1159/000181703 Andrew, 1980, Tuberculosis in patients with end-stage renal disease, Am J Med, 68, 59, 10.1016/0002-9343(80)90166-7 Lundin, 1979, Tuberculosis in patients undergoing maintenance hemodialysis, Am J Med, 67, 597, 10.1016/0002-9343(79)90240-7 Garcia-Leoni, 1990, High incidence of tuberculosis in renal patients, Eur J Clin Microbiol Infect Dis, 9, 283, 10.1007/BF01968062 Cengiz, 1996, Increased incidence of tuberculosis in patients undergoing hemodialysis, Nephron, 73, 421, 10.1159/000189104 Akpolat, 2009, Tuberculous peritonitis, Perit Dial Int, 29, S166, 10.1177/089686080902902S32 Chau, 2007, Diagnostic challenges of tuberculosis peritonitis in patients with and without end-stage renal failure, Clin Infect Dis, 45, e141, 10.1086/523727 Wang, 2011, Eosinophilic peritonitis: an unusual manifestation of tuberculous peritonitis in peritoneal dialysis patient, J Chin Med Assoc, 74, 322, 10.1016/j.jcma.2011.05.009 Sanai, 2005, Systematic review: tuberculous peritonitis--presenting features, diagnostic strategies and treatment, Aliment Pharmacol Ther, 22, 685, 10.1111/j.1365-2036.2005.02645.x Chow, 2003, Indication for peritoneal biopsy in tuberculous peritonitis, Am J Surg, 185, 567, 10.1016/S0002-9610(03)00079-5 Uzunkoy, 2004, Diagnosis of abdominal tuberculosis: experience from 11 cases and review of the literature, World J Gastroenterol, 10, 3647, 10.3748/wjg.v10.i24.3647 Shen, 2013, Diagnostic accuracy of adenosine deaminase for tuberculous peritonitis: a meta-analysis, Arch Med Sci, 9, 601, 10.5114/aoms.2013.36904 Tuon, 2010, Adenosine deaminase and tuberculous meningitis--a systematic review with meta-analysis, Scand J Infect Dis, 42, 198, 10.3109/00365540903428158 Liang, 2008, Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis, Respir Med, 102, 744, 10.1016/j.rmed.2007.12.007 Tuon, 2006, Adenosine deaminase and tuberculous pericarditis--a systematic review with meta-analysis, Acta Trop, 99, 67, 10.1016/j.actatropica.2006.07.004 Voigt, 1989, Diagnostic value of ascites adenosine deaminase in tuberculous peritonitis, Lancet, 1, 751, 10.1016/S0140-6736(89)92574-9 Protopapas, 2003, Miliary tuberculous peritonitis mimicking advanced ovarian cancer, Gynecol Obstet Invest, 56, 89, 10.1159/000072919 Tzoanopoulos, 2003, The usefulness of PCR amplification of the IS6110 insertion element of M. tuberculosis complex in ascitic fluid of patients with peritoneal tuberculosis, Eur J Intern Med, 14, 367, 10.1016/S0953-6205(03)90003-3 Li, 2010, Peritoneal dialysis-related infections recommendations: 2010 update, Perit Dial Int, 30, 393, 10.3747/pdi.2010.00049 Goslee, 1976, Water as a source of potentially pathogenic mycobacteria, Am Rev Respir Dis, 113, 287 Poisson, 1983, Mycobacterium chelonei peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis (CAPD), Perit Dial Int, 3, 86, 10.1177/089686088300300210 Band, 1982, Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis, J Infect Dis, 145, 9, 10.1093/infdis/145.1.9 Song, 2012, Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases, Nephrol Dial Transplant, 27, 1639, 10.1093/ndt/gfr504 Miyashita, 2014, Mycobacterium avium complex-associated peritonitis with CAPD after unrelated bone marrow transplantation, Pediatr Int, 56, e96, 10.1111/ped.12463 Ellis, 2005, Nontuberculous mycobacterial exit-site infection and abscess in a peritoneal dialysis patient. A case report and review of the literature, Pediatr Nephrol, 20, 1016, 10.1007/s00467-005-1870-4 Lo, 2013, Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream, Perit Dial Int, 33, 267, 10.3747/pdi.2011.00184 Tse, 2007, A cluster of rapidly growing mycobacterial peritoneal dialysis catheter exit-site infections, Am J Kidney Dis, 50, e1, 10.1053/j.ajkd.2007.04.017 Bernardini, 2005, Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients, J Am Soc Nephrol, 16, 539, 10.1681/ASN.2004090773 Griffith, 2007, An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases, Am J Respir Crit Care Med, 175, 367, 10.1164/rccm.200604-571ST Wong, 2001, Simple and rational approach to the identification of Mycobacterium tuberculosis, Mycobacterium avium complex species, and other commonly isolated mycobacteria, J Clin Microbiol, 39, 3768, 10.1128/JCM.39.10.3768-3771.2001 Miles, 2009, Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients, Kidney Int, 76, 622, 10.1038/ki.2009.202 1987, Report of a working party of the British Society for Antimicrobial Chemotherapy, Lancet, 1, 845 Kerr, 1983, Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis, Ann Intern Med, 99, 334, 10.7326/0003-4819-99-3-334 Prasad, 2004, Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience, J Infect, 48, 96, 10.1016/S0163-4453(03)00119-1 Nagappan, 1992, Fungal peritonitis in continuous ambulatory peritoneal dialysis--the Auckland experience, Am J Kidney Dis, 20, 492, 10.1016/S0272-6386(12)70262-7 Eisenberg, 1986, Fungal peritonitis in patients receiving peritoneal dialysis: experience with 11 patients and review of the literature, Rev Infect Dis, 8, 309, 10.1093/clinids/8.3.309 Chan, 1994, Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients, Nephrol Dial Transplant, 9, 539, 10.1093/ndt/9.5.539 Michel, 1994, Fungal peritonitis in patients on peritoneal dialysis, Am J Nephrol, 14, 113, 10.1159/000168699 Prasad, 2005, Fungal peritonitis in peritoneal dialysis patients, Perit Dial Int, 25, 207, 10.1177/089686080502500302 Wang, 2000, Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center, Am J Kidney Dis, 36, 1183, 10.1053/ajkd.2000.19833 Goldie, 1996, Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes, Am J Kidney Dis, 28, 86, 10.1016/S0272-6386(96)90135-3 Scotter, 2004, Diagnosis of aspergillus peritonitis in a renal dialysis patient by PCR and galactomannan detection, J Clin Pathol, 57, 662, 10.1136/jcp.2003.015636 Lau, 2003, Early diagnosis of Exophiala CAPD peritonitis by 18S ribosomal RNA gene sequencing and its clinical significance, Diagn Microbiol Infect Dis, 46, 95, 10.1016/S0732-8893(03)00014-2 Chou, 2006, Gram-negative and polymicrobial peritonitis are associated with subsequent fungal peritonitis in CAPD patients, Perit Dial Int, 26, 607, 10.1177/089686080602600518 Vellanki, 2014, Aspergillus Niger peritonitis in a peritoneal dialysis patient treated with eculizumab, Ren Fail, 36, 631, 10.3109/0886022X.2014.882712 Andrews, 1996, Impaired outcome of continuous ambulatory peritoneal dialysis in immunosuppressed patients, Nephrol Dial Transplant, 11, 1104, 10.1093/oxfordjournals.ndt.a027463 Tebben, 1993, Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis, Kidney Int, 44, 191, 10.1038/ki.1993.230 Zaruba, 1991, Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years’ experience, Am J Kidney Dis, 17, 43, 10.1016/S0272-6386(12)80249-6 Robitaille, 1995, Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience, Perit Dial Int, 15, 77, 10.1177/089686089501500118 Wadhwa, 1996, Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients, Adv Perit Dial, 12, 189 Williams, 2000, No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients, Perit Dial Int, 20, 352, 10.1177/089686080002000319 Lo, 1996, A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis, Am J Kidney Dis, 28, 549, 10.1016/S0272-6386(96)90466-7 Hughes, 2014, Selection and evolution of resistance to antimicrobial drugs, IUBMB Life, 66, 521, 10.1002/iub.1278 Boeschoten, 1991, Changing antimicrobial resistance in CAPD peritonitis?, Contrib Nephrol, 89, 87, 10.1159/000419755 van Esch, 2014, 32 years’ experience of peritoneal dialysis-related peritonitis in a university hospital, Perit Dial Int, 34, 162, 10.3747/pdi.2013.00275 Kitterer, 2015, Microbiological Surveillance of peritoneal dialysis associated peritonitis: antimicrobial susceptibility profiles of a referral center in Germany over 32 years, PLoS One, 10, e0135969, 10.1371/journal.pone.0135969 Zelenitsky, 2000, Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998, Am J Kidney Dis, 36, 1009, 10.1053/ajkd.2000.19103 Oliveira, 2012, Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center, Int Urol Nephrol, 44, 1529, 10.1007/s11255-011-0107-7 Ozisik, 2015, The changing trends of peritoneal dialysis related peritonitis and novel risk factors, Ren Fail, 37, 1027, 10.3109/0886022X.2015.1052952 Prasad, 2014, Microbiology and outcomes of peritonitis in northern India, Perit Dial Int, 34, 188, 10.3747/pdi.2012.00233 Kim, 2004, Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center’s experience over one decade, Perit Dial Int, 24, 424, 10.1177/089686080402400506 Santoianni, 2008, A 15 year-review of peritoneal dialysis-related peritonitis: microbiological trends and patterns of infection in a teaching hospital in Argentina, Rev Argent Microbiol, 40, 17 Fontan, 2009, Treatment of peritoneal dialysis-related peritonitis with ciprofloxacin monotherapy: clinical outcomes and bacterial susceptibility over two decades, Perit Dial Int, 29, 310, 10.1177/089686080902900316 McGuire, 2015, Effects of a statewide protocol for the management of peritoneal dialysis-related peritonitis on microbial profiles and antimicrobial susceptibilities: a retrospective five-year review, Perit Dial Int, 35, 722, 10.3747/pdi.2014.00117 Rocha, 2012, Temporal trends in peritonitis rates, microbiology and outcomes: the major clinical complication of peritoneal dialysis, Blood Purif, 33, 284, 10.1159/000337377 Gupta, 2011, Epidemiology of culture isolates from peritoneal dialysis peritonitis patients in southern India using an automated blood culture system to culture peritoneal dialysate, Nephrology (Carlton), 16, 63, 10.1111/j.1440-1797.2010.01355.x Szeto, 2007, Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases, Clin J Am Soc Nephrol, 2, 245, 10.2215/CJN.03180906 Barretti, 2012, Peritoneal dialysis-related peritonitis due to Staphylococcus aureus: a single-center experience over 15 years, PLoS One, 7, e31780, 10.1371/journal.pone.0031780 Fahim, 2010, Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases, Nephrol Dial Transplant, 25, 3386, 10.1093/ndt/gfq222 Ariano, 2002, Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients, Perit Dial Int, 22, 335, 10.1177/089686080202200306 Camargo, 2014, Peritoneal dialysis-related peritonitis due to coagulase-negative Staphylococcus: a review of 115 cases in a Brazilian center, Clin J Am Soc Nephrol, 9, 1074, 10.2215/CJN.09280913 Dryden, 1992, The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients, Epidemiol Infect, 109, 97 Szeto, 2008, Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases, Clin J Am Soc Nephrol, 3, 91, 10.2215/CJN.03070707 Govindarajulu, 2010, Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases, Perit Dial Int, 30, 311, 10.3747/pdi.2008.00258 Troidle, 1996, Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci, Kidney Int, 50, 1368, 10.1038/ki.1996.451 Yip, 2011, Clinical course and outcomes of single-organism Enterococcus peritonitis in peritoneal dialysis patients, Perit Dial Int, 31, 522, 10.3747/pdi.2009.00260 Szeto, 2006, Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases, Kidney Int, 69, 1245, 10.1038/sj.ki.5000037 Yip, 2006, Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients, Perit Dial Int, 26, 191, 10.1177/089686080602600213 Barretti, 2009, Evolution of gram-negative bacilli susceptibility in peritoneal dialysis-related peritonitis in Brazil: a single center’s experience over nine years, Perit Dial Int, 29, 230, 10.1177/089686080902900219 Feng, 2014, Escherichia coli peritonitis in peritoneal dialysis: the prevalence, antibiotic resistance and clinical outcomes in a South China dialysis center, Perit Dial Int, 34, 308, 10.3747/pdi.2013.00012 Chao, 2013, Citrobacter peritoneal dialysis peritonitis: rare occurrence with poor outcomes, Int J Med Sci, 10, 1092, 10.7150/ijms.6251 Chao, 2014, Acinetobacter peritoneal dialysis peritonitis: a changing landscape over time, PLoS One, 9, e110315, 10.1371/journal.pone.0110315 Chao, 2013, Peritoneal dialysis peritonitis by anaerobic pathogens: a retrospective case series, BMC Nephrol, 14, 111, 10.1186/1471-2369-14-111 Perez-Fontan, 2002, Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis, Am J Kidney Dis, 39, 337, 10.1053/ajkd.2002.30553 Chen, 2016, Long-term exit-site gentamicin prophylaxis and gentamicin resistance in a peritoneal dialysis program, Perit Dial Int, 36, 387, 10.3747/pdi.2015.00162 Annigeri, 2001, Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection, Perit Dial Int, 21, 554, 10.1177/089686080102100604 Lobbedez, 2004, Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years, Nephrol Dial Transplant, 19, 3140, 10.1093/ndt/gfh494 Pierce, 2012, The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis, Perit Dial Int, 32, 525, 10.3747/pdi.2011.00183 Iglesias Lamas, 2011, Assessing resistance to gentamicin following its daily use to treat peritoneal catheter infections, Nefrologia, 31, 613 Cavdar, 2008, Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience, Ren Fail, 30, 417, 10.1080/08860220801964228 Paul, 1998, Mycobacterium phlei peritonitis: a rare complication of chronic peritoneal dialysis, Pediatr Nephrol, 12, 67, 10.1007/s004670050407 Mansoor, 1994, Cryptococcal peritonitis in peritoneal dialysis patients: a case report, Clin Nephrol, 41, 230 Flynn, 1996, Fusarium peritonitis in a child on peritoneal dialysis: case report and review of the literature, Perit Dial Int, 16, 52, 10.1177/089686089601600113